Abstract
Purpose
To assess the effect of a pedometer use in men aged between 50 and 59 years presenting lower urinary tract symptoms (LUTS).
Methods
A single-center, not blind clinical trial with two parallel groups and equal randomization was performed with 38 men aged 50–59 years with LUTS. All patients received guidance and encouragement to physical activity practice. Only the intervention group received a Pedometer with a goal of 10,000 steps/day. After a period of 12 weeks, the groups were compared through the following variables: number of steps/day, IPSS score, flexibility, anthropometric values and Maximum Oxygen Consumption (VO2max).
Results
The number of steps per day in the intervention group was 9753 ± 1549 compared to 6212 ± 1152 in the control group (p = 0.004). Pedometer use efficacy was a 50% risk reduction of not achieve the goal of 10,000 steps per day. Regarding IPSS score, the intervention group achieved lower scores (6.95 ± 2.85 vs. 10.16 ± 3.23, p = 0.007). Pedometer use efficacy was a 94% risk reduction of not achieve more than 30% reduction in IPSS score.
In VO2max, the intervention group performed better than the control group (34.84 ± 3.25 vs. 32.58 ± 6.89; p = 0.011). There was no difference in flexibility and anthropometric values between the groups.
Conclusions
The use of pedometer in LUTS patients provided an increase in the number of steps/day, a decrease in LUTS score and an improvement in VO2max measure.
Clinical Trial Registration
Trial url: www.ensaiosclinicos.gov.br/rg/RBR-4vynk5/. Register Number: RBR-4vynk5 .
Similar content being viewed by others
Data availability
The data and material are available through request.
References
Robertson C, Link CL, Onel E et al (2007) The impact of lower urinary tract symptoms and comorbidities on quality of life : the Bach and UREPIK studies. BJU Int 99:347–354
Parsons JK, Bergstrom J, Silberstein J et al (2008) Prevalence and characteristics of lower urinary tract symptoms in men aged or 80 years. Urology 72:318–321
Parsons JK (2007) Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178:395–440
Parsons JK, Kashefi C (2008) Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53:1228–1235
Rohrmann S, Smit E, Giovannucci E et al (2004) Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the third national health and nutrition examination survey. Am J Epidem 159:390–397
Brum CS, Rezende EC, De Lima JR, Santos IC, Netto JM, Figueiredo AA (2013) Association of lower urinary tract symptoms and maximal oxygen uptake (Vo2max) in men aged 50 to 59 years: a case-control study. Urology 82(4):876–880
Albright C, Thompson DL (2006) The effectiveness of walking in preventing cardiovascular disease in women; a review of the current literature. J Women’s Health 15(3):271–280
Iwane M, Arita M, Tomimoto S, Satani O, Matsumoto M, Miyashita K, Nishio I (2000) Walking 10,000 steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension. Hypertens Res 23(6):573–580
Tudor-Locke C, Bassett DR, Swartz AM et al (2004) A preliminary study of one year of pedometer self-monitoring. Ann Behav Med 28(3):158–162
Barry MJ, Fowler FJ, Oleary MP et al (1992) The American urological association symptom index for benign prostatic hyperplasia. J Urol 148:1549–1557
Clarke TC, Norris T, Schiller JS (2017) Early release of selected estimates based on data from the 2016 national health interview survey
- World Health Organization (2017) Physical activity [Fact sheet]. http://www.who.int/mediacentre/factsheets/fs385/en/
Tudor-Locke C, Williams JE, Reis JP, Pluto D (2002) Utility of pedometers for assessing physical activity. Sports Med 32:795–808
Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA (2005) Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health ANd Nutrition Examination Survey. BJU Int 96:77–82
Pashootan P, Ploussard G, Cocaul A, de Gouvello A, Desgrandchamps F (2015) Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort. BJU Int 116:124–130
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177:1395–1400
Rohrmann S, Smit E, Giovannucci E et al (2004) Association of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 159:390
Joseph MA, Harlow SD, Wei JT et al (2003) Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157:906
Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JM et al (2003) Risk factors for lower urinary tract symptoms in a population based sample of African-American men. Am J Epidemiol 157:906–914
Hammarsten J, Högstedt B (2001) Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39:151–158
Giovannucci E, Rimm EB, Chute CG et al (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140:989
Haidinger G, Temml C, Schatzl G et al (2000) Risk factors for lower urinary tract symptoms in elderly men. For the prostate study group of the Austrian society of urology. Eur Urol 37:413–420
Buchheit M, Gindre C (2006) Cardiac parasympathetic regulation: respective associations with cardiorespiratory fitness and training load. Am J Physiol Heart Circ Physiol 291:451–458
Silva V, Grande AJ, Peccin MS (2019) Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev 4(4):CD12044
Funding
There was no funding to declare.
Author information
Authors and Affiliations
Contributions
LCMA: protocol/project development, data collection, data management, data analysis, manuscript writing, manuscript editing. CSB: data collection, data management, data analysis, manuscript writing. HEL: protocol/project development, manuscript editing. JMBN: protocol/project development, manuscript editing. AAF: protocol/project development, data analysis, manuscript writing, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors states that there is no conflict of interest to report.
Ethics approval
Número do CAAE: 42684915.1.0000.5133 Issuing authority: Plataforma Brasil. Número do Parecer do CEP: 1.043.224 Issuing authority: Comitê de Ética em Pesquisa do Hospital Universitário da Universidade Federal de Juiz de Fora.
Consent to participate
All patients assigned an informed consent to participate in the present clinical trial.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Agostini, L.C.M., Brum, C.S., Lopes, H.E. et al. Evaluation of pedometer use in men with lower urinary tract symptoms: a randomized clinical trial. Int Urol Nephrol 53, 2231–2236 (2021). https://doi.org/10.1007/s11255-021-02970-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02970-z